![Chris Valosky](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chris Valosky
Vertrieb & Marketing bei PEAR THERAPEUTICS, INC.
Aktive Positionen von Chris Valosky
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PEAR THERAPEUTICS, INC. | Vertrieb & Marketing | - | - |
Karriereverlauf von Chris Valosky
Ehemalige bekannte Positionen von Chris Valosky
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Vertrieb & Marketing | - | - |
Ausbildung von Chris Valosky
Kelley School of Business | Masters Business Admin |
The Ohio State University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Sales & Marketing | 2 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Pear Therapeutics, Inc.
![]() Pear Therapeutics, Inc. Medical SpecialtiesHealth Technology Pear Therapeutics, Inc. is a commercial-stage healthcare company pioneering a new class of software-based medicines, sometimes referred to as Prescription Digital Therapeutics (PDT), which use software to treat diseases directly. The firm aims to redefine medicine by discovering, developing, and delivering clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. It has a pipeline of products and product candidates across therapeutic areas, including the first three PDTs with disease treatment claims from the FDA. The company’s lead product, reSET, for the treatment of substance use disorder, was the first PDT to receive marketing authorization from the FDA to treat disease. Its second product, reSET-O, for the treatment of opioid use disorder, was the first PDT to receive Breakthrough Designation. Pear's third product, Somryst for the treatment of chronic insomnia, was the first PDT submitted through the FDA's traditional 510(k) pathway while simultaneously reviewed through the FDA's Software Precertification Pilot Program. The company was founded on December 1, 2020 and is headquartered in Boston, MA. | Health Technology |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Chris Valosky
- Erfahrung